APDN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Applied Dna Sciences Inc (APDN).


$6.69M Market Cap.

As of 12/17/2024 5:00 PM ET (MRY) • Disclaimer

APDN Market Cap. (MRY)


APDN Shares Outstanding (MRY)


APDN Assets (MRY)


Total Assets

$12.79M

Total Liabilities

$3.82M

Total Investments

$0

APDN Income (MRY)


Revenue

$3.43M

Net Income

-$6.99M

Operating Expense

$15.04M

APDN Cash Flow (MRY)


CF Operations

-$13.71M

CF Investing

-$407.90K

CF Financing

$13.40M

APDN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

APDN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$12,789,040 (-6.32%)

$13,651,577 (-38.69%)

$22,265,114 (54.44%)

$14,416,756 (27.12%)

Assets Current

$8,047,670 (-0.97%)

$8,126,570 (-59.25%)

$19,943,129 (76.52%)

$11,297,801 (24.46%)

Assets Non-Current

$4,741,370 (-14.18%)

$5,525,007 (137.94%)

$2,321,985 (-25.55%)

$3,118,955 (37.80%)

Goodwill & Intangible Assets

$2,698,975 (0.00%)

$2,698,975 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$9,142,617 (84.66%)

$4,951,159 (-61.65%)

$12,911,829 (16.18%)

$11,113,668 (94.36%)

Property Plant & Equipment Net

$1,292,395 (-37.75%)

$2,076,032 (-6.61%)

$2,222,988 (-26.49%)

$3,023,915 (136.68%)

Cash & Equivalents

$7,181,095 (-9.12%)

$7,901,800 (-48.40%)

$15,314,282 (130.29%)

$6,649,988 (-15.63%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$252,785 (-6.53%)

$270,435 (-52.01%)

$563,557 (100.55%)

$281,000 (-45.01%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$438,592 (32.90%)

$330,027 (-45.20%)

$602,244 (-56.04%)

$1,369,933 (175.44%)

Trade & Non-Trade Receivables

$362,013 (41.69%)

$255,502 (-91.67%)

$3,067,544 (9.40%)

$2,804,039 (1343.01%)

Trade & Non-Trade Payables

$1,793,427 (-21.01%)

$2,270,388 (-37.31%)

$3,621,751 (21.07%)

$2,991,343 (55.28%)

Accumulated Retained Earnings (Deficit)

-$309,672,755 (-2.39%)

-$302,447,147 (-3.40%)

-$292,500,088 (-2.95%)

-$284,122,092 (-5.29%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$684,115 (0.00%)

$684,115 (0%)

$0 (0%)

$0 (0%)

Total Debt

$739,161 (-40.28%)

$1,237,760 (0%)

$0 (0%)

$0 (0%)

Debt Current

$545,912 (9.49%)

$498,598 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$193,249 (-73.86%)

$739,162 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$3,820,955 (-56.48%)

$8,779,165 (-6.17%)

$9,356,175 (183.19%)

$3,303,810 (-41.34%)

Liabilities Current

$2,398,124 (-15.72%)

$2,845,421 (-32.01%)

$4,185,308 (27.90%)

$3,272,343 (-23.29%)

Liabilities Non-Current

$1,422,831 (-76.02%)

$5,933,744 (14.75%)

$5,170,867 (16332.67%)

$31,467 (-97.70%)

APDN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,431,420 (-74.33%)

$13,367,443 (-26.43%)

$18,168,677 (101.25%)

$9,027,738 (367.40%)

Cost of Revenue

$2,414,541 (-69.18%)

$7,834,011 (-40.27%)

$13,115,037 (188.57%)

$4,544,832 (449.01%)

Selling General & Administrative Expense

$11,447,894 (-10.22%)

$12,751,644 (-15.54%)

$15,097,360 (17.53%)

$12,845,372 (28.05%)

Research & Development Expense

$3,593,750 (-3.78%)

$3,735,078 (-4.86%)

$3,926,043 (-5.72%)

$4,164,434 (25.37%)

Operating Expenses

$15,041,644 (-8.77%)

$16,486,722 (-13.33%)

$19,023,403 (6.68%)

$17,831,547 (30.74%)

Interest Expense

$0 (0%)

$0 (0%)

-$7,200 (47.35%)

-$13,675 (-111.81%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$7,088,306 (29.28%)

-$10,022,916 (-21.20%)

-$8,270,059 (42.08%)

-$14,278,439 (-9.59%)

Net Income to Non-Controlling Interests

-$95,785 (-26.27%)

-$75,857 (-3398.94%)

-$2,168 (-127.09%)

$8,003 (574.96%)

Net Income

-$6,992,521 (29.70%)

-$9,947,059 (-20.31%)

-$8,267,891 (42.13%)

-$14,286,442 (-9.67%)

Preferred Dividends Income Statement Impact

$233,087 (0%)

$0 (0%)

$110,105 (0%)

$0 (0%)

Net Income Common Stock

-$7,225,608 (27.36%)

-$9,947,059 (-18.73%)

-$8,377,996 (41.36%)

-$14,286,442 (-9.64%)

Weighted Average Shares

$3,966,026 (-69.67%)

$13,075,416 (45.81%)

$8,967,704 (29.65%)

$6,916,999 (76.50%)

Weighted Average Shares Diluted

$3,966,026 (-69.67%)

$13,075,416 (45.81%)

$8,967,704 (29.65%)

$6,916,999 (76.50%)

Earning Before Interest & Taxes (EBIT)

-$6,992,521 (29.70%)

-$9,947,059 (-20.20%)

-$8,275,091 (42.13%)

-$14,300,117 (-10.76%)

Gross Profit

$1,016,879 (-81.62%)

$5,533,432 (9.49%)

$5,053,640 (12.73%)

$4,482,906 (306.18%)

Operating Income

-$14,024,765 (-28.04%)

-$10,953,290 (21.59%)

-$13,969,763 (-4.65%)

-$13,348,641 (-6.49%)

APDN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$407,904 (62.78%)

-$1,095,808 (-123.84%)

-$489,553 (80.79%)

-$2,548,695 (-139.61%)

Net Cash Flow from Financing

$13,398,596 (0%)

$0 (0%)

$18,126,596 (23.27%)

$14,704,855 (-24.34%)

Net Cash Flow from Operations

-$13,711,397 (-120.52%)

-$6,217,677 (30.74%)

-$8,976,706 (32.95%)

-$13,387,955 (-20.15%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$720,705 (90.15%)

-$7,313,485 (-184.45%)

$8,660,337 (803.07%)

-$1,231,795 (-117.04%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$1,062,360 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$407,904 (-1119.52%)

-$33,448 (93.17%)

-$489,553 (80.79%)

-$2,548,695 (-139.61%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$1,665,581 (-325.39%)

Issuance (Purchase) of Equity Shares

$13,398,596 (0%)

$0 (0%)

$18,126,596 (10.73%)

$16,370,436 (-12.44%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$572,293 (-44.65%)

$1,033,889 (-58.95%)

$2,518,665 (51.00%)

$1,668,003 (66.62%)

Depreciation Amortization & Accretion

$696,425 (-48.88%)

$1,362,249 (5.56%)

$1,290,480 (52.82%)

$844,438 (195.54%)

APDN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

29.60% (-28.50%)

41.40% (48.92%)

27.80% (-44.06%)

49.70% (-12.96%)

Profit Margin

-210.60% (-183.06%)

-74.40% (-61.39%)

-46.10% (70.88%)

-158.30% (76.53%)

EBITDA Margin

-183.50% (-185.83%)

-64.20% (-67.19%)

-38.40% (74.23%)

-149.00% (77.21%)

Return on Average Equity (ROAE)

-112.40% (11.36%)

-126.80% (-35.33%)

-93.70% (16.26%)

-111.90% (37.73%)

Return on Average Assets (ROAA)

-59.50% (-3.12%)

-57.70% (-2.30%)

-56.40% (38.76%)

-92.10% (16.04%)

Return on Sales (ROS)

-203.80% (-173.92%)

-74.40% (-63.52%)

-45.50% (71.28%)

-158.40% (76.31%)

Return on Invested Capital (ROIC)

-657.10% (-95.86%)

-335.50% (-50.45%)

-223.00% (48.51%)

-433.10% (59.18%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.36 (77.58%)

-1.59 (-31.03%)

-1.22 (53.34%)

-2.6 (-11.86%)

Price to Sales Ratio (P/S)

0.75 (-36.57%)

1.18 (112.19%)

0.56 (-86.49%)

4.13 (-73.67%)

Price to Book Ratio (P/B)

0.73 (-78.07%)

3.34 (196.18%)

1.13 (-68.96%)

3.63 (-47.77%)

Debt to Equity Ratio (D/E)

0.42 (-76.42%)

1.77 (144.55%)

0.72 (144.11%)

0.3 (-69.85%)

Earnings Per Share (EPS)

-1.82 (-139.47%)

-0.76 (18.28%)

-0.93 (55.07%)

-2.07 (37.65%)

Sales Per Share (SPS)

0.86 (-15.36%)

1.02 (-49.56%)

2.03 (55.25%)

1.3 (164.71%)

Free Cash Flow Per Share (FCFPS)

-3.56 (-644.77%)

-0.48 (54.73%)

-1.06 (54.17%)

-2.3 (26.04%)

Book Value Per Share (BVPS)

2.31 (508.18%)

0.38 (-73.68%)

1.44 (-10.39%)

1.61 (10.14%)

Tangible Assets Book Value Per Share (TABVPS)

2.54 (203.58%)

0.84 (-66.25%)

2.48 (19.15%)

2.08 (-21.86%)

Enterprise Value Over EBIT (EV/EBIT)

1 (200.00%)

-1 (0.00%)

-1 (50.00%)

-2 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.58 (177.66%)

-0.74 (46.93%)

-1.4 (32.92%)

-2.09 (15.20%)

Asset Turnover

0.28 (-63.53%)

0.78 (-36.50%)

1.22 (109.97%)

0.58 (257.06%)

Current Ratio

3.36 (17.51%)

2.86 (-40.06%)

4.76 (38.00%)

3.45 (62.27%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$14,119,301 (-125.87%)

-$6,251,125 (33.96%)

-$9,466,259 (40.60%)

-$15,936,650 (-30.56%)

Enterprise Value (EV)

-$3,632,540 (-156.97%)

$6,376,080 (-34.81%)

$9,780,388 (-65.17%)

$28,081,691 (-9.63%)

Earnings Before Tax (EBT)

-$6,992,521 (29.70%)

-$9,947,059 (-20.31%)

-$8,267,891 (42.13%)

-$14,286,442 (-9.67%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$6,296,096 (26.66%)

-$8,584,810 (-22.91%)

-$6,984,611 (48.09%)

-$13,455,679 (-6.57%)

Invested Capital

$1,250,007 (-13.38%)

$1,443,141 (-47.82%)

$2,765,524 (-38.47%)

$4,494,425 (592.88%)

Working Capital

$5,649,546 (6.98%)

$5,281,149 (-66.49%)

$15,757,821 (96.35%)

$8,025,458 (66.79%)

Tangible Asset Value

$10,090,065 (-7.88%)

$10,952,602 (-50.81%)

$22,265,114 (54.44%)

$14,416,756 (37.95%)

Market Capitalization

$6,691,510 (-59.51%)

$16,526,809 (13.53%)

$14,557,248 (-63.92%)

$40,350,187 (1.50%)

Average Equity

$6,429,696 (-18.02%)

$7,842,986 (-12.24%)

$8,936,847 (-29.99%)

$12,764,310 (76.00%)

Average Assets

$12,141,992 (-29.52%)

$17,228,425 (15.89%)

$14,866,729 (-4.19%)

$15,516,493 (30.62%)

Invested Capital Average

$1,064,130 (-64.11%)

$2,964,857 (-20.10%)

$3,710,654 (12.38%)

$3,301,761 (171.33%)

Shares

10,299,385 (-24.59%)

13,658,520 (6.02%)

12,882,520 (72.09%)

7,486,120 (45.57%)